Cytokine therapeutics : lessons from interferon αGUTTERMAN, J. U.Proceedings of the National Academy of Sciences of the United States of America. 1994, Vol 91, Num 4, pp 1198-1205, issn 0027-8424Article

Psoriasis and alpha-interferonQUESADA, J. R; GUTTERMAN, J. U.Lancet (British edition). 1986, Num 8496, pp 1466-1468, issn 0140-6736Article

Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration routeROSENBLUM, M. G; RISO, A; GUTTERMAN, J. U et al.Cancer chemotherapy and pharmacology. 1986, Vol 16, Num 3, pp 273-276, issn 0344-5704Article

Down-regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFNα) therapyMAXWELL, B. L; TALPAZ, M; GUTTERMAN, J. U et al.International journal of cancer. 1985, Vol 36, Num 1, pp 23-28, issn 0020-7136Article

Interferons and cell growth regulationQUESADA, J. R; GUTTERMAN, J. U.European journal of cancer & clinical oncology. 1984, Vol 20, Num 10, pp 1213-1215, issn 0277-5379Article

Synergistic antiproliferative activity of leukocyte interferon in combination with α-difluoromethylornithine against human cells in culture = Activité antiproliférative synergique de l'interféron de leucocyte associé à l'alphadifluorométhylornithine contre les cellules humains en cultureROSENBLUM, M. G; GUTTERMAN, J. U.Cancer research (Baltimore). 1984, Vol 44, Num 6, pp 2339-2340, issn 0008-5472Article

Biological therapy of human cancerGUTTERMAN, J. U.Cancer. 1992, Vol 70, Num 4, pp 906-908, issn 0008-543X, SUPConference Paper

Chronic myelogenous leukemia ― past, present, and futureKANTARJIAN, H. M; TALPAZ, M; GUTTERMAN, J. U et al.Hematologic pathology. 1988, Vol 2, Num 2, pp 91-120, issn 0886-0238Article

Differential expression of p21^ras gene products among histological subtypes of fresh primary human lung tumorsKURZROCK, R; GALLICK, G. E; GUTTERMAN, J. U et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1530-1534, issn 0008-5472Article

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancerADAMS, F; QUESADA, J. R; GUTTERMAN, J. U et al.JAMA, the journal of the American Medical Association. 1984, Vol 252, Num 7, pp 938-941, issn 0098-7484Article

Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemiaKURZROCK, R; TALPAZ, M; GUTTERMAN, J. U et al.The American journal of medicine. 1992, Vol 93, Num 1, pp 41-48, issn 0002-9343Article

Treatment of cyclic neutropenia with very low doses of GM-CSFKURZROCK, R; TALPAZ, M; GUTTERMAN, J. U et al.The American journal of medicine. 1991, Vol 91, Num 3, pp 317-318, issn 0002-9343Article

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicityOWEN-SCHAUB, L. B; GUTTERMAN, J. U; GRIMM, E. A et al.Cancer research (Baltimore). 1988, Vol 48, Num 4, pp 788-792, issn 0008-5472Article

c-K-ras codon 12 GGT-CGT point mutation: an infrequent event in human lung cancerMILICI, A; BLICK, M; MURPHY, E et al.Biochemical and biophysical research communications (Print). 1986, Vol 140, Num 2, pp 699-705, issn 0006-291XArticle

Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202YAN, D.-H; YONG WEN; SPOHN, B et al.Oncogene (Basingstoke). 1999, Vol 18, Num 3, pp 807-811, issn 0950-9232Article

Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junctionAJANI, J. A; ROTH, J. A; RYAN, M. B et al.Journal of clinical oncology. 1993, Vol 11, Num 1, pp 22-28, issn 0732-183XArticle

Suppression of chronic myelogenous leukemia colony growth by interleukin-4ESTROV, Z; MARKOWITZ, A. B; KURZROCK, R et al.Leukemia. 1993, Vol 7, Num 2, pp 214-220, issn 0887-6924Article

Escalated therapy for refractory urothelial tumors : methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorLOGOTHETIS, C. J; DEXEUS, F. H; SELLA, A et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 8, pp 667-672, issn 0027-8874Article

Phase I study of a combination of recombinant tumor necrosis factor-α and recombinant interferon-γ in cancer patientsKURZROCK, R; FEINBERG, B; TALPAZ, M et al.Journal of interferon research. 1989, Vol 9, Num 4, pp 435-444, issn 0197-8357Article

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromesSAROJ VADHAN-RAJ; KEATING, M; LE MAISTRE, A et al.The New England journal of medicine. 1987, Vol 317, Num 25, pp 1545-1552, issn 0028-4793Article

Treatment of hairy cell leukemia with recombinant α-interferonQUESADA, J. R; HERSH, E. M; MANNING, J et al.Blood. 1986, Vol 68, Num 2, pp 493-497, issn 0006-4971Article

Leukocyte interferon conjugated to β-D-galactosidase for receptor studies: a preliminary reportMAXWELL, B. L; FRITSCHE, H. A; PARK, H. R et al.Journal of interferon research. 1985, Vol 5, Num 4, pp 565-570, issn 0197-8357Article

Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemiaTALPAZ, M; MAVLIGIT, G; KEATING, M et al.Annals of internal medicine. 1983, Vol 99, Num 6, pp 789-792, issn 0003-4819Article

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaSCHILLING, P. J; KURZROCK, R; KANTARJIAN, H et al.Cancer. 1991, Vol 68, Num 7, pp 1536-1537, issn 0008-543XArticle

Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaCLAXTON, D; KANTARJIAN, H; KURZROCK, R et al.Acta haematologica. 1990, Vol 83, Num 3, pp 149-151, issn 0001-5792, 3 p.Article